XML 43 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Summary of Significant Accounting Policies - Segments (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2017
USD ($)
item
Mar. 31, 2016
Jan. 01, 2017
USD ($)
Dec. 31, 2016
USD ($)
Segment Information        
Number of operating segments | item 1      
Recent Accounting Pronouncements        
Prepaid and other current assets $ 6,394     $ 5,386
Other assets $ 3,193     $ 3,020
Bayer | Revenues percentage | Customer concentration        
Segment Information        
Percentages of revenue recognized   51.00%    
CytomX | Revenues percentage | Customer concentration        
Segment Information        
Percentages of revenue recognized 48.00% 3.00%    
Roche | Revenues percentage | Customer concentration        
Segment Information        
Percentages of revenue recognized 27.00% 37.00%    
Sanofi | Revenues percentage | Customer concentration        
Segment Information        
Percentages of revenue recognized 21.00%      
Maximum | Accounting Standards Update 2014-09        
Recent Accounting Pronouncements        
Number of contracts requiring evaluation | item 10      
Federal | New accounting pronouncement | Accounting Standards Update 2016-09        
Recent Accounting Pronouncements        
Net deferred tax assets     $ 9,200  
Valuation allowance     9,200  
State | New accounting pronouncement | Accounting Standards Update 2016-09        
Recent Accounting Pronouncements        
Net deferred tax assets     1,200  
Valuation allowance     $ 1,200